**Core Concept**
Diethylstilboestrol (DES) is a synthetic non-steroidal estrogen that was historically used to prevent miscarriage and premature labor. However, it has been linked to various adverse effects, particularly in the context of intrauterine exposure. This has significant implications for reproductive health and cancer risk in exposed individuals.

**Why the Correct Answer is Right**
Intrauterine exposure to DES is a well-documented risk factor for the development of clear cell adenocarcinoma (CCA) of the vagina. This rare malignancy is characterized by its aggressive behavior and poor prognosis. The exact mechanism by which DES leads to CCA is not fully understood but is thought to involve disruption of normal embryonic development and subsequent malignant transformation of vaginal epithelial cells. The affected individuals are typically female offspring of mothers who were exposed to DES during pregnancy.

**Why Each Wrong Option is Incorrect**
**Option A:** Squamous cell carcinoma of the cervix is not directly associated with intrauterine DES exposure. While DES has been linked to various reproductive tract abnormalities, its primary connection is with clear cell adenocarcinoma of the vagina, not squamous cell carcinoma of the cervix.
**Option B:** Adenocarcinoma of the endometrium is a type of cancer that affects the lining of the uterus, but it is not directly linked to intrauterine DES exposure. Although DES has been shown to affect the reproductive tract, its primary association is with clear cell adenocarcinoma of the vagina, not endometrial cancer.
**Option D:** Sarcoma of the uterus is a rare type of cancer that affects the connective tissue of the uterus, but it is not directly associated with intrauterine DES exposure. While DES has been linked to various reproductive tract abnormalities, its primary connection is with clear cell adenocarcinoma of the vagina, not uterine sarcoma.

**Clinical Pearl / High-Yield Fact**
DES-exposed individuals are at increased risk of developing clear cell adenocarcinoma of the vagina, emphasizing the importance of monitoring and surveillance in these patients. A thorough medical history, including inquiry about intrauterine exposure to DES, is crucial in identifying high-risk patients.

**✓ Correct Answer: C. Clear cell adenocarcinoma of vagina**